CAN-FITE BIOPHARMA LTD. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.7 ILa | -3.57% |
|
-3.57% | +3.85% |
| 05-12 | Transcript : Can-Fite BioPharma Ltd. - Special Call | |
| 05-09 | Can-Fite BioPharma Ltd. Announces FDA Grants IND Clearance for Namodenoson to Treat MASH Patients in a Phase IIb Study | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Biopharmaceuticals
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 10.88M | - | - | - | |||
| 89.87B | ||||||
| 37.57B | ||||||
| 32.75B | ||||||
| 26.47B | ||||||
| 14.25B |
